Shares of Ping An Good Doctor (01833) rose by 10.49% in early trading, currently quoted at HK$7.27, with a trading turnover of HK$64.989 million.

Recently, the China team of Roche Pharmaceuticals visited the headquarters of Ping An Good Doctor. The two parties engaged in in-depth discussions on commercial insurance innovation, comprehensive tumor disease management, chronic and special disease services, and internet healthcare, clarifying multi-dimensional cooperation directions and implementation plans. They jointly explored a new integrated model of "pharmaceuticals + insurance + health services". Furthermore, Ping An Good Doctor's AI doctor service—Ping An Smart Family Doctor—has been fully integrated into the entire ecosystem of Ping An Group's apps, including Ping An Financial Butler and Ping An Good Car Owner, reaching a potential user base of 90 million monthly active users. Users can access Ping An Smart Family Doctor through various Ping An channels such as insurance, banking, securities, and car owner services.

For the first quarter of this year, Ping An Good Doctor reported total revenue of RMB 1.159 billion, a year-on-year increase of 9.1%. Adjusted net profit reached RMB 84.4 million, marking a 45.8% increase compared to the same period last year. As of the end of the reporting period, the company served over 7,500 paying enterprise clients in the past 12 months, a near 89% year-on-year growth. Additionally, the number of users for its AI doctor service continues to grow, exceeding 5.6 million. CICC previously noted that considering the company is expected to continue benefiting from synergistic empowerment within its group, coupled with continuous operational optimization driven by AI, it initiated coverage on Ping An Good Doctor with an Outperform rating and a target price of HK$14.20.